Nuvation Bio (NUVB) Invested Capital (2024 - 2026)
Nuvation Bio (NUVB) posted quarterly Invested Capital of $5.8 million for Q1 2026, up 1.85% year-over-year from $5.7 million in Q1 2025, and up 1.15% quarter-over-quarter from $5.7 million in Q4 2025.
Nuvation Bio (NUVB) Invested Capital (2024 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Invested Capital for 3 consecutive years, with $5.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital rose 1.85% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $22.7 million (down 29.08% YoY), while the FY2025 annual figure was $5.7 million, down 8.9% from the prior year.
- Invested Capital rose to $5.8 million in Q1 2026 per NUVB's latest filing, from $5.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $11.6 million in Q2 2024 and bottomed at $5.6 million in Q2 2025.
- Historically, Invested Capital has averaged $6.8 million across 3 years, with a median of $5.8 million in 2025.
- Annual changes were most pronounced in 2025 — Invested Capital plunged 52.01% — and 2026, when it grew 1.85%.
- Nuvation Bio's Invested Capital stood at $6.3 million in 2024, then declined by 8.9% to $5.7 million in 2025, then increased by 1.15% to $5.8 million in 2026.
- Business Quant data shows NUVB's Invested Capital at $5.8 million in Q1 2026, $5.7 million in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 5.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.89 Mn |
| Mar 31, 2026 | 5.79 Mn |
| Dec 31, 2025 | 5.72 Mn |
| Sep 30, 2025 | 5.62 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 5.69 Mn |
| Dec 31, 2024 | 6.28 Mn |
| Sep 30, 2024 | 8.43 Mn |
| Jun 30, 2024 | 11.63 Mn |